empagliflozin vs semaglutide Two target trial emulation studies examined whether the GLP-1 receptor agonists #semaglutide and #dulaglutide are superior to #empagliflozin, an SGLT-2 inhibitor, in mortality and cardiovascular outcomes. was found to be more Ozempic outperforms another diabetes drug

No medical writing assistance was used

from 1958 to 1985

Es zeigen sich Kardiomyopathien (Krankheiten des Herzmuskels), Skelettmuskelschwche und auch Hypoglykmien (chronische Unterzuckerung)

Amanda Lightbody, founder of The Rainbow Crosswalk, a nonprofit Pride organization in New Brunswick, Canada, remembers using food as a child to calm herself down during moments of anxiety or uncertainty

The 26-page lawsuit, filed on behalf of a Louisiana woman who says she was severely injured after taking the two diabetes drugs, is the first to allege that they can cause gastrointestinal injuries

These findings have generated interest in whether GLP-1-based therapies might benefit neurodegenerative conditions such as Alzheimer's disease